Award recordCONTRACT

DIPLOMAT PHARMACY, INC.

PIID VA26116P0380· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2016· $21,028 net obligations· UEI SYLDGKWADRP7· MI

Description

CARBOZANTINIB 100MG CAPS (COMETRIQ)NDC: 42388-0012-14

First action · last action
2015-12-08 · 2018-02-14
Transactions
3
First transaction's obligation
$28,207
Base + all options value (sum of deltas)
$21,028
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$28,207$0Base award · 2015-12-08 · this action $28,207 · running total $28,207Modification P00001 · 2018-02-09 · this action -$7,052 · running total $21,155Modification P00002 · 2018-02-14 · this action -$127 · running total $21,028
  • Base2015-12-08+$28,207= $28,207
  • Mod P000012018-02-09-$7,052= $21,155
  • Mod P000022018-02-14-$127= $21,028
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-12-08+$28,207$28,207CARBOZANTINIB 100MG CAPS (COMETRIQ)NDC: 42388-0012-14
Mod P00001· FUNDING ONLY ACTION2018-02-09−$7,052$21,155CARBOZANTINIB 100MG CAPS (COMETRIQ)NDC: 42388-0012-14
Mod P00002· FUNDING ONLY ACTION2018-02-14−$127$21,028CARBOZANTINIB 100MG CAPS (COMETRIQ)NDC: 42388-0012-14

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI SYLDGKWADRP7)

AwardOffice · PSC / listingNet obligationsFY
VA25717P0325257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA25917E3532NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$27,499FY2017
VA25816P2311258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS$6,941FY2016
VA25716P2173257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$6,875FY2016
VA25716P1914257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$6,875FY2016
VA25816P2185258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS$6,875FY2016

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26116P0380_3600_-NONE-_-NONE- · retrieved 2026-09-26.